Literature DB >> 10896400

A pleomorphic adenoma of the lacrimal gland in a dog.

K Hirayama, Y Kagawa, K Tsuzuki, T Kotani, Y Azuma, T Yoshino, H Taniyama.   

Abstract

A 13-year-old female mongrel dog had a pleomorphic adenoma of the lacrimal gland in the right upper orbit. The tumor measured 3.8 x 3.0 x 3.3 cm, appeared white, round, and firm, and pressed the right globe and surrounding tissues. Histopathologically, the tumor had a thin connective tissue capsule and was composed of tubules with two cell types, some resembling luminal epithelial cells making up the tubular structures and the other of myoepithelial cells. Epithelial tubules were disposed in an adenomatous fashion and separated from each other by proliferating pleomorphic myoepithelial cells. Immunohistochemically, large numbers of the luminal epithelial cells revealed an immunopositive reaction against keratin/cytokeratin (AE1/AE3), and some epithelial cells reacted against cytokeratin 14. Spindle-shaped myoepithelial cells revealed an immunopositive reaction against cytokeratin 14, alpha-smooth muscle actin, and vimentin. A small number of myoepithelial cells reacted against desmin. S-100 protein immunopositivity was frequently found in luminal epithelial cells and rarely in the pleomorphic myoepithelial cells. Glial fibrillary acidic protein positivity was commonly found in myoepithelial cells, myxoid matrices, and intracystic materials, but not in luminal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896400     DOI: 10.1354/vp.37-4-353

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  2 in total

1.  Concurrent lacrimal gland melanocytoma and ocular melanocytosis in a dog.

Authors:  Ikki Mitsui; Seigi Nishimura
Journal:  J Vet Diagn Invest       Date:  2021-09-13       Impact factor: 1.569

2.  Computed tomographic imaging characteristics of the normal canine lacrimal glands.

Authors:  Allison L Zwingenberger; Shin A Park; Christopher J Murphy
Journal:  BMC Vet Res       Date:  2014-05-22       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.